- Home
- BZUN vs TLSA Comparison
BZUN vs TLSA Comparison
Compare BZUN & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- TLSA
- Stock Information
- Founded
- BZUN 2007
- TLSA 2013
- Country
- BZUN China
- TLSA United Kingdom
- Employees
- BZUN N/A
- TLSA N/A
- Industry
- BZUN Catalog/Specialty Distribution
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- BZUN Consumer Discretionary
- TLSA Health Care
- Exchange
- BZUN Nasdaq
- TLSA Nasdaq
- Market Cap
- BZUN 240.6M
- TLSA 240.0M
- IPO Year
- BZUN N/A
- TLSA 2000
- Fundamental
- Price
- BZUN $3.24
- TLSA $1.75
- Analyst Decision
- BZUN Strong Buy
- TLSA
- Analyst Count
- BZUN 1
- TLSA 0
- Target Price
- BZUN $4.20
- TLSA N/A
- AVG Volume (30 Days)
- BZUN 204.4K
- TLSA 263.4K
- Earning Date
- BZUN 11-21-2025
- TLSA 01-01-0001
- Dividend Yield
- BZUN N/A
- TLSA N/A
- EPS Growth
- BZUN N/A
- TLSA N/A
- EPS
- BZUN N/A
- TLSA N/A
- Revenue
- BZUN $1,349,630,922.00
- TLSA N/A
- Revenue This Year
- BZUN $6.27
- TLSA N/A
- Revenue Next Year
- BZUN $3.61
- TLSA N/A
- P/E Ratio
- BZUN N/A
- TLSA N/A
- Revenue Growth
- BZUN 7.73
- TLSA N/A
- 52 Week Low
- BZUN $2.12
- TLSA $0.63
- 52 Week High
- BZUN $4.88
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- BZUN 38.98
- TLSA 39.33
- Support Level
- BZUN $3.18
- TLSA $1.78
- Resistance Level
- BZUN $3.29
- TLSA $2.04
- Average True Range (ATR)
- BZUN 0.14
- TLSA 0.14
- MACD
- BZUN -0.02
- TLSA -0.02
- Stochastic Oscillator
- BZUN 18.99
- TLSA 15.66
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.